New patent expiration for Organon drug SINGULAIR
Annual Drug Patent Expirations for SINGULAIR Singulair is a drug marketed by Organon and is included in three NDAs. There […]
New patent expiration for Organon drug SINGULAIR Read Post »
Patent Expiration
New patent expiration for Otsuka drug ABILIFY
Annual Drug Patent Expirations for ABILIFY Abilify is a drug marketed by Otsuka and Otsuka Pharm Co Ltd and is
New patent expiration for Braintree drug HALFLYTELY
Annual Drug Patent Expirations for HALFLYTELY Halflytely is a drug marketed by Braintree and is included in one NDA. There
New patent expiration for Braintree drug HALFLYTELY Read Post »
New patent expiration for Collegium Pharm drug NUCYNTA ER
Annual Drug Patent Expirations for NUCYNTA+ER Nucynta Er is a drug marketed by Collegium Pharm Inc and is included in
New patent expiration for Collegium Pharm drug NUCYNTA ER Read Post »
Drug Patent Expirations for the Week of October 16, 2022
SUMAVEL DOSEPRO (sumatriptan succinate) Endo ventures ltd Patent: 8,343,130 Expiration: Oct 18, 2022 See More … For more information on
Drug Patent Expirations for the Week of October 16, 2022 Read Post »
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO
Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
New patent expiration for Redhill drug MOVANTIK
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Redhill and is included in one NDA. It
New patent expiration for Cosette drug WELCHOL
Annual Drug Patent Expirations for WELCHOL Welchol is a drug marketed by Cosette and is included in four NDAs. It
New patent expiration for Sprout Pharms drug ADDYI
Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA.
New patent expiration for Sprout Pharms drug ADDYI Read Post »
